Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic Cancer
Clinical trial NCT06677762 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06677762
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-10
- Primary completion
- 2025-06-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.